Promoter methylation and response to chemotherapy and radiation in esophageal cancer. - Wikidata - wikimedia - TriplyDB

Promoter methylation and response to chemotherapy and radiation in esophageal cancer.

Promoter methylation and response to chemotherapy and radiation in esophageal cancer.

http://www.wikidata.org/entity/Q53346515

about

Emerging therapeutic targets in esophageal adenocarcinoma Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.Cancer biomarker discovery and development in gastrointestinal cancers: early detection research network-a collaborative approach.Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction.Epigenetics: principles and practice.Ablation of breast cancer stem cells with radiation.Methylation of CHFR sensitizes esophageal squamous cell cancer to docetaxel and paclitaxel Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies.Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma.DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses Review of the development of DNA methylation as a marker of response to neoadjuvant therapy and outcomes in rectal cancer.Use of Percutaneous Sonographically Guided Microwave Ablation Therapy to Treat Inoperable Malignant Liver Tumours.Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.Locally advanced esophageal adenocarcinoma: current standards and molecular predictors of outcome.Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.Epigenetic biomarkers in esophageal cancer.Novel diagnostic and prognostic biomarkers in esophageal cancer.Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer.Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer.Emerging molecular targets in esophageal cancers Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine.Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas.Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy?Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.Loss of Reprimo and S100A2 expression in human gastric adenocarcinoma.Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma

P2860

Q26751209-E494C6D9-F093-4D72-A621-B445A6D96018 Q30506094-7612F02B-4B88-4DA3-95B7-56AFC77A1C37 Q33323380-96E1F78A-7BC9-48CE-82F2-68103807EE6F Q33429064-A011DAC0-9448-4BD4-AD0C-8E2412EDF023 Q33907989-EFAD16B0-D795-4D05-A245-A7548D4B05AD Q34634735-44AE1D5A-4938-4E67-8E7A-3C0C252BC2E5 Q35098483-FAB22254-AB07-4503-A28F-27ED44ABEACC Q35116818-FA86155F-23F9-4058-ACF5-08251372D6CE Q35184495-8F242F6F-6F61-432D-A4A0-4AC87DCC6292 Q35205710-D33DF3B0-AB75-484A-97EA-49BD5E1B031E Q35606943-8DC4DAAA-94AF-495F-B6D2-AE6B219E9720 Q35667377-1CE98380-C7AB-4B81-AD7D-CC79D9348D76 Q35879988-29FCB20B-6243-452E-A5E9-513D41C244E1 Q36418030-7883F575-CD65-4DD6-AE90-A1FDD79538C4 Q36450457-B4FD82C4-01AF-44A9-85FA-43A83716FEAB Q36489832-C3715A20-24D9-455B-8E24-E965979F1656 Q36698563-66DEA98E-48D2-49BA-B0A0-A3AC9BD30D0C Q37179405-D25DA424-75CE-48BC-8E30-BCA04E7A8487 Q37203411-14ACCC56-0F8E-404D-96A8-35C9CAE3D3E0 Q37824622-5450B4B3-1C18-4E31-B0F1-282B7774DE09 Q37992481-A8E77C82-F5B8-4709-816F-FE39D5947994 Q38149245-7366D2F4-615E-45B9-ACED-9B970BB25E26 Q38623918-299CBCAE-D381-451F-A9FB-FE5DEC2E5B29 Q42034570-6D2DBAEB-E3DB-4339-8372-4810B3913D55 Q42267831-819FADE1-2531-402E-872D-8DBD074C5911 Q42587971-B212D294-0DCC-4F35-81BD-6728F0223070 Q43492270-3B6A4A93-25FE-41CD-88F7-549340EBFBE5 Q43524369-F3A3D24F-253F-4389-AA02-24B06F4FD140 Q50033803-6B97E8F1-750F-40E9-84A1-3C0E4A27EB9C Q53295389-CA31B331-233D-4550-9C7A-2A6807EB36E0 Q57617318-552B1E96-F8B9-4EBE-AE49-550C3F8D5DC9

P2860

Promoter methylation and response to chemotherapy and radiation in esophageal cancer.

http://www.wikidata.org/entity/Q53346515

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Promoter methylation and response to chemotherapy and radiation in esophageal cancer.

@en

Promoter methylation and response to chemotherapy and radiation in esophageal cancer.

@nl

type

label

Promoter methylation and response to chemotherapy and radiation in esophageal cancer.

@en

Promoter methylation and response to chemotherapy and radiation in esophageal cancer.

@nl

prefLabel

Promoter methylation and response to chemotherapy and radiation in esophageal cancer.

@en

Promoter methylation and response to chemotherapy and radiation in esophageal cancer.

@nl

P1433

Q53346515-4FACDEA5-DC69-4988-9D24-8ED63DFB33A2

P1476

Q53346515-292641AA-CFE5-48BD-83A4-8B4F1E0B30BA

P2093

Q53346515-0D90FC15-EDFC-4D11-9888-24E053F9199B

Q53346515-1048787F-5FEE-496E-BFE3-E042475EDA2E

Q53346515-29F2A4A0-6DE4-4AB5-9C4A-2C02C31445BD

Q53346515-3B9A1A2E-D19E-43C7-A1C0-3E4B60D5C64B

Q53346515-4140834E-9F1F-4DB5-8266-157D6ACC6855

Q53346515-72A3DB2B-11E5-4869-9565-37CAEA14AD89

Q53346515-7D6C23F2-834A-4F9C-BEF9-F613F8E5E9D3

Q53346515-8B1874EE-3A07-461E-9B69-C08EF725FB0A

Q53346515-92E61244-28E4-4A3B-8E9A-80FE4E288DE4

Q53346515-9B9543AE-902B-4132-A9A2-DE979CCB794F

P304

Q53346515-FA95BF08-A8A7-4350-95AB-37CF5B6859B5

P31

Q53346515-85125CE5-8C87-46D3-88B9-A00850188CF2

P356

Q53346515-CB1219CF-A8E4-4696-AD61-FCC7B5FA4AB4

P407

Q53346515-CE9315BF-254B-43D3-9B99-D9362040140E

P433

Q53346515-12F27A10-7DBB-49DD-AC23-5B1B6C5626D5

P478

Q53346515-C148DC3F-2AC1-4DDD-BE33-C126967BD223

P50

Q53346515-2C061B08-FB72-4DCD-8302-76FCB1E62C0F

P577

Q53346515-4C4EB777-0497-4CA2-821C-099A45EFDB59

P5875

Q53346515-992EB308-939F-4919-8627-0E6EEB40C828

P698

Q53346515-95C222A8-1F76-4E07-B76A-22E106E81CDE

P921

Q53346515-F9E91D78-8154-4414-9A0A-212ED8695FA1

P356

J.CGH.2006.03.007

P1433

Clinical Gastroenterology and Hepatology

P1476

Promoter methylation and response to chemotherapy and radiation in esophageal cancer

@en

P2093

Austin Doyle

http://www.w3.org/2001/XMLSchema#string

Bogdan Paun

http://www.w3.org/2001/XMLSchema#string

Bruce D Greenwald

http://www.w3.org/2001/XMLSchema#string

Carmit Mantzur

http://www.w3.org/2001/XMLSchema#string

Fumiaki Sato

http://www.w3.org/2001/XMLSchema#string

James P Hamilton

http://www.w3.org/2001/XMLSchema#string

John M Abraham

http://www.w3.org/2001/XMLSchema#string

Mark J Krasna

http://www.w3.org/2001/XMLSchema#string

Martin J Edelman

http://www.w3.org/2001/XMLSchema#string

Mohan Suntharalingam

http://www.w3.org/2001/XMLSchema#string

P304

701-708

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2006.03.007

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7103530

http://www.w3.org/2001/XMLSchema#string

P698

16678495

http://www.w3.org/2001/XMLSchema#string

P921